Lipocine Inc.
LPCN
$1.98
-$0.07-3.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.00M | 1.98M | 4.32M | 4.21M | 3.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.00M | 1.98M | 4.32M | 4.21M | 3.67M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.00M | 1.98M | 4.32M | 4.21M | 3.67M |
| SG&A Expenses | 3.85M | 3.76M | 3.65M | 3.93M | 4.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.13M | 12.35M | 10.63M | 9.79M | 10.14M |
| Operating Income | -12.13M | -10.37M | -6.31M | -5.58M | -6.47M |
| Income Before Tax | -11.43M | -9.63M | -5.48M | -4.51M | -5.37M |
| Income Tax Expenses | 0.00 | 200.00 | 200.00 | 200.00 | 700.00 |
| Earnings from Continuing Operations | -11.43 | -9.63 | -5.48 | -4.51 | -5.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.43M | -9.63M | -5.48M | -4.51M | -5.37M |
| EBIT | -12.13M | -10.37M | -6.31M | -5.58M | -6.47M |
| EBITDA | -12.07M | -10.31M | -6.25M | -5.52M | -6.42M |
| EPS Basic | -1.96 | -1.77 | -1.02 | -0.84 | -1.00 |
| Normalized Basic EPS | -1.22 | -1.10 | -0.64 | -0.53 | -0.63 |
| EPS Diluted | -1.96 | -1.77 | -1.04 | -0.89 | -1.05 |
| Normalized Diluted EPS | -1.22 | -1.10 | -0.65 | -0.54 | -0.64 |
| Average Basic Shares Outstanding | 23.24M | 21.79M | 21.46M | 21.40M | 21.39M |
| Average Diluted Shares Outstanding | 23.24M | 21.79M | 21.80M | 21.73M | 21.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |